Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

ONC seeks 52% budget increase for 2016

The Obama administration is requesting a 52 percent budgetary increase for the Office of the National Coordinator for Health IT next year to support interoperability, “optimization” of health IT, consumer engagement in care and President Obama’s new Precision Medicine Initiative.

Rep. Cruz introduces Obamacare Repeal Act

Sen. Ted Cruz (R-Texas) has unveiled an "Obamacare Repeal Act" that would repeal the act "as if such Act had not been enacted," according to the National Review Online. 

White House’s $215M precision medicine initiative ushers in new era in healthcare

The White House announced that it is pumping $215 million into federal health and science agencies so they can develop infrastructure that allows data to flow between medical clinics to labs that sequence the human genome and gather other data, reports Politico.

Thumbnail

NYT editorial: Don’t kill the medical device tax

The Congressional movement to eliminate the 2.3 percent medical device tax is misguided and may do more harm than good, according to an editorial in The New York Times.  

Thumbnail

P4P: More details needed but potential game-changer

After many assurances over the past year that the Office of the National Coordinator for Health IT and the Centers for Medicare & Medicaid Services (CMS) want to relieve some of the regulatory burden providers face, the Department of Health & Human Services (HHS) this week announced an aggressive plan to move to pay-for-performance rather than volume.

House Energy and Commerce Committee proposal seeks to advance medical treatments

The House Energy and Commerce Committee published a discussion draft of new legislation, called the 21st Century Cures Act, that would promote the development of new medical advances for drugs and medical devices, reports Roll Call. 

Industry coalition backs federal call for value-based care

An industry coalition representing some of the largest healthcare systems and insurers is supporting a Centers for Medicare and Medicaid Services plan to accelerate the movement towards value-based care, reports The New York Times. 

Thumbnail

House Committee's 393-page draft proposal includes health IT, telemedicine provisions

The House of Representatives Committee on Energy and Commerce has released a 393-page draft document, called the 21st Century Cures Act, which contains a wide array of provisions that seek to advance medicine—including those directly related to health IT.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.